ZTEST Electronics Inc. ("ZTEST" or the "Company") (CSE:ZTE)(OTCID:ZTSTF) announces that it has granted 900,000 stock options to the Directors, Officers and Employees of the Company, exercisable at $0.
Pyruvate dictates redox balance and cell size, establishing metabolism as a dominant regulator of cellular fitness, unveiling new strategies to modulate cancer, regeneration, and diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback